Marie-Magdeleine Ruchoux

Title: Marie-Magdeleine Ruchoux: Innovator in Anti-Idiotypic Antibodies

Introduction

Marie-Magdeleine Ruchoux is a prominent inventor based in Tours, France. She has made significant contributions to the field of biotechnology, particularly in the development of anti-idiotypic antibodies. Her work focuses on the vascular endothelial growth factor, which plays a crucial role in various physiological processes.

Latest Patents

Marie-Magdeleine Ruchoux holds a patent for "Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs." This patent describes an anti-idiotypic vascular endothelial growth factor antibody, an Fab fragment, and pharmaceutical compositions that act as ligands for the human KDR receptor or the murine flk-1 receptor, while not being a ligand for flt. This innovation has potential applications in therapeutic treatments.

Career Highlights

Ruchoux is affiliated with the Centre National de la Recherche Scientifique, a leading research institution in France. Her work at this esteemed organization has allowed her to explore and develop groundbreaking solutions in the field of medical research.

Collaborations

Marie-Magdeleine Ruchoux has collaborated with notable colleagues, including Frederic Jonca and Nathalie Ortega. These partnerships have contributed to her research and the advancement of her innovative projects.

Conclusion

Marie-Magdeleine Ruchoux is a trailblazer in the field of biotechnology, with her patent on anti-idiotypic antibodies showcasing her innovative spirit. Her contributions continue to influence medical research and therapeutic development.